Tirzepatide yielded greater cardiometabolic benefits, especially in total cholesterol, LDL cholesterol, and weight loss, ...

Diazoxide choline extended-release tablets demonstrated favorable safety profile across 4 years among patients with Prader-Willi Syndrome.

Veligrotug demonstrated significant improvements in proptosis, diplopia, and clinical activity score among patients with active thyroid eye disease.

Glucopilot dynamic dosing algorithm was associated with improved glycemic control especially among subgroups with ...

Thyroid cancer burden attributable to high BMI was increasing between 1990 and 2021 in the US, especially among men and older ...

Tirzepatide was superior to semaglutide in achieving standard and intensive cardiometabolic targets among patients with type ...

Adolescents with PCOS demonstrated comparable weight loss to their reproductively normal peers after undergoing bariatric ...

Adrenal adenomas were associated with attenuated weight loss among patients with obesity or overweight using GLP-1 or GIP/GLP ...

For adults with obesity or overweight, tirzepatide-linked improvements in cardiometabolic risk factors are associated with the degree of weight reduction.

COCPs were associated with improved obesity outcomes among patients with hyperandrogenic PCOS, but metformin added little ...

PCOS was associated with an increased risk for vascular events including stroke among women with thrombotic disease, and a lower mean age.

Hormone therapy as an adjunctive to tirzepatide was associated with greater weight loss than tirzepatide alone among postmenopausal women.